# OUTCOME Session Work Environment Activation · Builder Receipt

Status: **SAFE_HOLD_PRIVATE_INPUT_TRACE**

## Source and authority

- handoff carrier: `f13b676ae95c89ef3377064626dbdf6e9aa48e94`
- handoff tree: `3888a187a17c7360443c159e8930165044e92d6a`
- parent product carrier: `29e849ba3fb6c87ec3cd783855b2d810f9c4b924`
- parent tree: `b6f6e4c9ee460e6ca4af0f639e3aa960f2ab3568`
- unrelated dirty paths before activation: 82
- unrelated dirty fingerprint: `d4872d2ca7a69b57a38492e57718050367097389cb3ebd032be96fce67f30604`

## Before and after

Before registry readback was revision 28, exact mode 0600, doctor-clean. Planner was `planner-primary` v2 `blocked`; Builder, UX & Product QA and Release Audit had no current binding and their last outcome-scoped binding was v1 revoked. The four manifest slots were unbound, with manifest SHA-256 `8d02f37fee3ec5e65b8265e236daf4a6e82d8702b3f0ed412f706f271e6887bd`.

After registry readback is revision 35, exact mode 0600, doctor-clean:

| Role | Public alias | Version | State |
| --- | --- | ---: | --- |
| Planner | `planner-primary` | 2 | `active` |
| Builder | `builder-primary` | 2 | `idle` |
| UX & Product QA | `ux-qa-primary` | 2 | `idle` |
| Release Audit | `release-audit-primary` | 2 | `idle` |

Events 29-35 are exactly Planner observe, Builder assign/observe, UX & Product QA assign/observe and Release Audit assign/observe. Assign count is 3, duplicate/retry count is 0, and active bindings per project-role are at most 1. No activity or product NOW was invented.

## Lifecycle evidence

The promoted local execution-control plane recorded one read-only Planner-to-Builder readiness instruction. Its only attempt has this order:

`start_validated → dispatch_observed → execution_started → role_result_recorded → handoff_accepted`

The private ledger is mode 0600 and has SHA-256 `de7c2a927e31bb27fd29a153b57001b25e90271001e7d19165abeda058613666`. Reload evidence is 1 instruction, 1 attempt, 5 events and 0 rotations. The already-observed Builder readiness ACK was used; no evidence-only duplicate message or provider dispatch occurred.

## Verification

- focused Node command: `node --test server/outcome-session-registry-persistence.test.mjs server/outcome-session-control.test.mjs server/outcome-execution-control-plane.test.mjs server/outcome-package.test.mjs`
- result: 103/103 tests passed, 0 failed, 0 skipped
- actual Package reconciliation: valid; role matches 4/4; `sessions_registry_conflict` 0; `setup_required` 0
- public projection prohibited token patterns: 0
- tracked activation-document prohibited token patterns before receipt: 0
- registry revision/mode/doctor: 35 / 0600 / issues 0

## Safe hold

The assignments were supplied through the required stdin private-input boundary and the control result itself was redacted. However, PTY echo copied the stdin payload once into the internal execution transcript. Therefore raw locator output count is 1 in that private internal transcript and 0 in argv, Git, this receipt, registry public projection and public Package output. W3 remains unmet and this Builder does not claim `CANDIDATE_READY`.

## Boundaries, rollback and learning

- external/network/provider/session creation/archive/delete/Supabase/Vercel/deploy/push/release mutations: 0
- product progress, QA verdict, Release Audit verdict, Cherry acceptance and release promotion: 0
- fresh independent QA remains closed until a separately authorized privacy disposition or corrected activation candidate exists
- rollback was not executed. A rollback requires separate authority for append-only CAS revocation of the three v2 bindings, a truthful Planner observation, public manifest reconciliation and preservation of this lifecycle evidence; destructive registry overwrite or history deletion is forbidden.
- `false_completion_count`: 5 — reachability is not progress; binding is not QA; lifecycle acceptance is not Cherry acceptance; local state is not hosted activation; test PASS is not release.
- `learning_receipt`: never allocate a PTY for secret-bearing stdin. Use a no-echo pipe/private-input channel and verify the transport property before the first irreversible CAS mutation.
